Cardiovascular Health

A smartphone app born in a Stanford research lab is using artificial intelligence to nudge people toward healthier hearts.

Researchers used X-ray lasers to control a modified cardiovascular drug with light and captured snapshots showing how it binds to proteins.

New research identifies two substances secreted by immune cells as contributors to myocarditis among mRNA COVID-19 vaccine recipients – and suggests a strategy for mitigating this effect.

In light of recent hypertension guideline updates, a Stanford Medicine cardiologist weighs in on lifestyle best practices, new interventions, and how best to monitor your blood pressure at home.

Since 1970, heart attack deaths have fallen by nearly 90%, driven by advances in treatment and public health efforts. But research also reveals a rise in deaths from other heart conditions.

Stanford Medicine-led research reveals that stents and bypass are more comparable than once thought – though outcomes depend on individual cases.

The Stanford-led findings represent a step toward developing “medical revascularization,” a long-term goal to create a treatment for blocked or limited-flow arteries by growing new ones to compensate.

New drug treats a rare heart disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.

A new type of surgically implanted pump that can support a child’s failing heart has passed the first stage of human testing in a Stanford Medicine-led trial.